BackNabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc Gross Profit

Gross Profit analysis for NBRV.

Quarterly Gross Profit

$3.15M
↓ 26.83% YoY

As of Mar 31, 2023

Annual Gross Profit (TTM)

$5.93M
↓ 63.63% YoY

Trailing 12 months ending Mar 31, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin